Baxter International Inc. vs Abbvie Inc.
BAX vs ABBV — side-by-side comparison from reported financials. BAX leads 1, ABBV leads 10 of 11 comparable metrics.
Baxter International Inc.
BAX · Healthcare
$24.35+1.88%Mixed
Abbvie Inc.
ABBV · Healthcare
$276.43+1.47%Mixed
| Metric | BAX | ABBV |
|---|---|---|
| Price | $24.35 | $276.43 |
| Market cap | $12.6B | $488B |
| Revenue (TTM) | $11.5B | $64.4B |
| Revenue growth | -9.4% | +1.8% |
| Net margin | -9.3% | 9.8% |
| Free cash flow | $931M | $18.2B |
| Net cash (debt) | $1.97B | ($56.2B) |
| 1-year price return | +8.2% | +19.8% |
| P/E | — | 77.4 |
| P/E vs own history (cheap-side %) | 9% | 23% |
| Dividend yield | 1.46% | 2.45% |
| Return on equity | -17% | 96% |
| Altman Z-score | 2.12 | 2.33 |
| CV checks passed | 8 of 10 | 9 of 10 |
| Employees | 37,500 | 57,000 |
Full résumé-style profiles: BAX CV · ABBV CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.